SERPINA1 and metabolic dysfunction-associated steatohepatitis: SERPINA1 MZ genotype carriage increased the risk of liver cirrhosis only in patients with ALD (OR 2.745; 95% CI 1.744–4.325) and NASH (OR 4.729; 95% CI 2.733–8.298), as shown in Table 2.